Patient autonomy in multiple sclerosis - Possible goals and assessment strategies

Journal of the Neurological Sciences

Volumn 331, Issue 1-2, 2013, Pages 2-9

  Heesen, C ^a   Kopke S ^b   Solari, A ^c   Geiger, F ^d   Kasper, J ^a,e  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Complex interventions; Immunotherapy decision making; Multiple sclerosis; Patient autonomy; Risk communication; Shared decision making

Indexed keywords

NATALIZUMAB;

ATTITUDE; CANCER PATIENT; CLINICAL COMPETENCE; HEALTH BEHAVIOR; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; IMMUNOTHERAPY; INTERPERSONAL COMMUNICATION; KNOWLEDGE; MEDICAL DECISION MAKING; MULTIPLE SCLEROSIS; PATIENT AUTONOMY; PATIENT PARTICIPATION; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; THEORY OF PLANNED BEHAVIOR;

EID: 84882454707     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.02.018     Document Type: Review

References (66)

1. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (Or it takes at least two to tango). Soc Sci Med 1997;44(5): 681-92.
2. GMC. Consent: Patients and Doctors Making Decisions Together. London: General Medical Council; 2008 [Available from: http://www.gmc-uk.org/static/ documents/ content/Consent-2008.pdf].
3. Barrat A. Evidence based medicine and shared decision making: the challenge of getting both evidence and preferences into health care. Patient Educ Couns 2008;73:407-12.
4. O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2009;3:CD001431.
5. Aktas O, Kieseier B, Hartung HP. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis. Trends Neurosci 2010;33(3):140-52.
6. Bruce JM, Lynch SG. Multiple sclerosis: MS treatment adherence-how to keep patients on medication? Nat Rev Neurol 2011;5(7(8)):421-2.
7. Zivadinov R, Salvi F, Weinstock-Guttman B. Regarding CCSVI andMS: a never-ending story or a new chapter? Eur J Vasc Endovasc Surg 2012;43(1):129-30.
8. Scholl I, Loon MK, Sepucha K, Elwyn G, Légaré F, Härter M, et al. Measurement of shared decisionmaking-a reviewof instruments. Z Evid Fortbild Qual Gesundhwes 2011;105:313-24.
9. Rogers R. A protection motivation theory of fear appeals and attitude change. J Psychol 1975;91:93-114.
10. Munro S, Lewin S, Swart T, Volmink J. A review of health behavior theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health 2007;7:104.
11. Schwarzer R. Selbstwirksamkeitserwartung [Self-efficacy]. In: Schwarzer R, Jerusalem M, Weber, editors. Gesundheitspsychologie Von A bis Z, Göttingen. Germany: Hogrefe; 2002. p. 521-4.
12. Lohaus A, Schmitt GM. KKG Questionnaire. Göttingen: Hogrefe; 1989.
13. Heesen C, Kleiter I, Nguyen F, Schäffler N, Kasper J, Köpke S, et al. Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists. Mult Scler 2010;16(12):1507-12.
14. Miller DT, Ross M. Self-serving biases in the attribution of causality: fact or fiction? Psychol Bull 1975;82(2):213-25.
15. Kasper J, Heesen C, Köpke S, Mühlhauser I, Lenz M. Why not? - Communicating stochastic information by use of unsorted frequency pictograms - randomised controlled trial. Psychosoc Med 2011;8 [Doc08. Epub 2011].
16. Janssens C. Perception of Prognostic Risk in Multiple Sclerosis [thesis]. Rotterdam: Erasmus University; 2003. Available from: http://www-fgg.eur.nl/ medbib/EURdiss/ 030521-Janssens-C/Janssens-C.html.
17. Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz L, Woloshins S. Helping doctors and patients make sense of health statistics. Psychol Sci Publ Interest 2007;8:53-96.
18. Kasper J, Köpke S, Mühlhauser I, Heesen C. Evidence-based patient information about treatment of multiple sclerosis - a phase one study on comprehension and emotional responses. Patient Educ Couns 2006;62:56-63.
19. Kasper J, Köpke S, Mühlhauser I, Nübling M, Heesen C. Informed shared decision making about immunotherapy for patients with multiple sclerosis (ISDIMS): a randomised controlled trial. Eur J Neurol 2008;15:1345-52.
20. Köpke S, Kasper J, Mühlhauser I, Nübling M, Heesen C. Patient education programme to enhance decision autonomy in mutiple sclerosis relapse management: a randomised controlled trial. Mult Scler 2008;00:1-9.
21. Bunge M, Mühlhauser I, Steckelberg A. What constitutes evidence-based patient information? Overview of discussed criteria, 78(3). , Patient education and counseling; 2010. p. 316-28 [Heesen 2004].
22. Heesen C, Kasper J, Segal J, Köpke S, Mühlhauser I. Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis. Mult Scler 2004;10:643-50.
23. Giordano A, Uccelli MM, Pucci E, Martinelli V, Borreani C, Lugaresi A, et al. The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients. Mult Scler 2010;16(1):100-11.
24. Solari A, Martinelli V, TrojanoM, Lugaresi A, Granella F, Giordano A, et al. SIMS-Trial group. An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. Mult Scler 2010;16(11):1393-405.
25. Hamann J, Neuner B, Kasper J. Participation preferences of patients with acute and chronic conditions. Health Expect 2007;10:358-63.
26. Degner LF, Sloan JA, Venkatesh P. The Control Preferences Scale. Can J Nurs Res 1997;29:21-43.
27. Giordano A, Mattarozzi K, Pucci E, Leone M, Casini F, Collimedaglia L, et al. Participation in medical decision-making: attitudes of Italians with multiple sclerosis. J Neurol Sci 2008;275(1-2):86-91.
28. Kryworuchko J, Stacey D, Bennett C, Graham ID. Appraisal of primary outcome measures used in trials of patient decision support. Patient Educ Couns 2008;73(3): 497-503.
29. Kasper J, Heesen C, Köpke S, Fulcher G, Geiger F. Patients and observers perceptions of involvement differ. Validation study on inter-relating measures for shared decision making. PLoS One October 2011;6(10):26255.
30. Entwistle VA, Prior M, Skea ZC, Francis J. Involvement in decision-making: a qualitative investigation of its meaning for people with diabetes. Soc Sci Med 2008;66: 362-75.
31. Ajzen I. Fromintentions to actions: a theory of planned behavior. In: Kuhl J, Beckmann J, editors. Action Control: From Cognition to Behavior. New York: Springer-Verlag; 1985. p. 11-39.
32. Krones T, Keller H, Becker A, Sönnichsen A, Baum E, Donner-Banzhoff N. The theory of planned behaviour in a randomized trial of a decision aid on cardiovascular risk prevention. Patient Educ Couns 2010;78:169-76.
33. Frosch DL, Légaré F, Fishbein M, Elwyn G. Adjuncts or adversaries to shared decision-making? Applying the integrative model of behavior to the role and design of decision support interventions in healthcare interactions. BMC Implement Sci 2009;4:73.
34. Sivell S, Edwards A, Elwyn G, Manstead AS. Understanding surgery choices for breast cancer: how might the Theory of Planned Behavior and the Common Sense Model contribute to decision support interventions? Health Expect 2011;1:6-19.
35. Fishbein M, Ajzen I. Belief, attitude, intention and behavior: an introduction to theory and research. Reading, MA: Addison-Wesley; 1975.
36. Kasper J, Köpke S, Fischer K, Backhus I, Schäffler N, Solari A, Heesen C: Applying the theory of planned behavior to multiple sclerosis patients' decisions on disease modifying therapy - questionnaire concept and validation. BMC Med Inform Decis Making in press.
37. McNutt R. Shared medical decision making, problems, process. JAMA 2004;292: 2516-8.
38. Mishel MH. The measurement of uncertainty in illness. Nurs Res 1981;30(5): 258-63.
39. Mishel MH. Reconceptualization of the uncertainty in illness theory. J Nurs Scholarsh 1990;22(4):256-62.
40. Kasper J, Légaré F, Scheibler F, Geiger F. Turning signals into meaning - 'shared decision making' meets communication theory. Health Expect 2010. http://dx.doi.org/ 10.1111/j.1369-7625.2011.00657.x.
41. Kasper J, Geiger F, Freiberger S, Schmidt A. Decision-related uncertainties perceived by people with cancer-modelling the subject of shared decision making. Psychooncology 2008;1:42-8.
42. Politi MC, Clark MA, Ombao H, Dizon D, Elwyn G. Communicating uncertainty can lead to less decision satisfaction: a necessary cost of involving patients in shared decision making? Health Expect 2011;14(1):84-91.
43. Geiger F, Liethmann K, Hoffmann F, Paschedag J, Kasper J. Investigating a training supporting shared decision making (IT'S SDM 2011): study protocol for a randomized controlled trial. Trials 2011;12:232.
44. Geiger F, Hartmann JT, Kasper J. The impact of the unknown and the unknowable: development and validation of a questionnaire assessing patients' decisional uncertainties. Onkologie 2011;34(Suppl. 6):107.
45. Kasper J, Kügow M, Heesen C, Mühlhauser I. Shared decision making (SDM) as a mutual negotiation of uncertainties. 2nd International Shared Decision Making Conference, University of Wales, Swansea, UK; September 2003. p. 2-4.
46. Geiger F. Shared decision making als Verhandlung von Ungewissheiten. Osnabrück: Universität Osnabrück; 2007 [http://repositorium.uni- osnabrueck. de/bitstream/urn:nbn:de:gbv:700-2007073014/2/E-Diss685-thesis.pdf].
47. Simon D, Schorr G, Wirtz M, Vodermaier A, Caspari C, Neuner B, et al. Development and first validation of the shared decision-making questionnaire (SDMQ). Patient Educ Couns 2006;63(3):319-27.
48. Kasper J, Hoffmann F, Heesen C, Köpke S, Geiger F. MAPPIN'SDM - the multifocal approach to sharing in shared decision making. PLoS One 2012;7:1-9.
49. Elwyn G, Hutchings H, Edwards A, Rapport F, Wensing M, Cheung WY, et al. The OPTION-scale: measuring the extent that clinicians involve patients in decision-making tasks. Health Expect 2005;8:34-42.
50. Geiger F, Liethmann K, Hoffmann F, Paschedag J, Kasper J. Of blind men and the elephant: introducing a compound measure for shared decision making integrating patient's, physician's and observer's view. Z Evid Fortbild Qual Gesundh wesen 2012;106(4):284-9.
51. Gold SM, Heesen C, Schulz H, Guder U, Mönch A, Gbadamosi J, et al. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler 2001;7:119-30.
52. Mohr DC, Boudewyn AC, Likosky W, Levine E, Goodkin DE. Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject. Ann Behav Med 2001;23(2):125-32.
53. Levy S, Herberman R, d'Angelo T, Lippman M. Mastectomy versus excisional biopsy: distress sequelae as a function of choice. J Clin Oncol 1989;7:367-75.
54. Martin LR, Jahng KH, Golin CE, DiMatteo MR. Physician facilitation of patient involvement in care: correspondence between patient and observer reports. Behav Med 2003;28:159-64.
55. Ogden J, Fuks K, Gardner M, Johnson S, McLean M, Martin P, et al. Doctors expressions of uncertainty and patient confidence. Patient Educ Couns 2002;48:171-6.
56. Johnson CG, Levenkron JC, Suchman AL, Manchester R. Does physician uncertainty affect patient satisfaction? J Gen Intern Med 1988;3:144-9.
57. Kiesler DJ, Auerbach S. Optimal matches of patient preferences for information, decision-making and interpersonal behaviour: evidence, models and interventions. Patient Educ Couns 2006;61:319-41.
58. O'Connor A. User Manual - Decisional Conflict Scale; 2010 [cited 2011 5 August]; Available from: http://decisionaid.ohri.ca/docs/develop/User-Manuals/ UM-Decisional- Conflict.pdf].
59. Légaré F, LeBlanc A, Hubert Robitaille H, Turcotte S. The decisional conflict scale: moving from the individual to the dyad level. Z Evid Fortbild Qual Gesundh wesen 2012;106(4):247-52.
60. Marteau TM, Dormandy E, Michie S. A measure of informed choice. Health Expect 2001;4(2):99-108.
61. Heesen C, Solari A, Giordano A, Kasper J, Köpke S. Decisions on multiple sclerosis immunotherapy: new treatment complexities urge patient engagement. J Neurol Sci 2011;306:192-7.
62. Köpke S, Kasper J, Fischer K, Schäffler N, Heesen C. Patient education program on diagnosis, prognosis and early therapy for persons with early multiple sclerosis. 6th International Shared Decision Making Conference (ISDM) Maastricht, The Netherlands; June 19-22. 2011.
63. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655.
64. Dalbert C. Die Ungewißheitstoleranzskala: Skaleneigenschaften und Validierungsbefunde. Hallesche Berichte zur Pädagogischen Psychologie; Nr. 1. Halle: Martin-Luther Universität Halle- Wittenberg, Institut für Pädagogik; 1999 [Available from: http://psydok.sulb.uni-saarland.de/ volltexte/2004/393/].
65. Ende J, Kazis L, Ash A, Moskowitz MA. Measuring patients' desire for autonomy: decision-making and information-seeking preferences among medical patients. J Gen Intern Med 1989;4:23-30.
66. Köpke, S. Entwicklung eines Schulungsprogramms und Evaluationskonzepts zur Kortisonbehandlung im akuten Schub der Multiplen Sklerose [Development of an educational programme and evaluation concept for corticoid treatment in acute relapses of multiple sclerosis]. Hamburg: University of Hamburg; 2003 (state examination thesis).